Buprenorphine Tablet
Product Images NDC 72162-1344

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 72162-1344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure of buprenorphine hydrochloride, showing its molecular arrangement including hydroxyl, methoxy, cyclopropyl, and tert-butyl groups.*

FDA Label Image

Image (Buprenorphine 02)

An instructional black-and-white illustration showing a person placing a sublingual tablet under the tongue. The image emphasizes the oral cavity with the tongue lifted to reveal the area beneath it, highlighting the correct placement for a sublingual tablet.*

FDA Label Image

Label (Lbl721621344)

Label for Buprenorphine Sublingual Tablets 2 mg, showing a package size of 30 tablets. The label includes the NDC number 72162-1344-3 and indicates the product is manufactured by Purdue Pharma L.P. and relabeled by Bryant Ranch Prepack. The label also features storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.